Xconomy National

Archives

by in

Entry	Author	Date	Location
RetroSense Therapeutics Licenses Vision Restoration Technology From Wayne State	Sarah Schmid	11/01/11	Detroit
Upping the Ante: San Diego Life Sciences Startups Raise More Cash	Bruce V. Bigelow	09/07/11	San Diego
Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News	Bruce V. Bigelow	07/21/11	San Diego
Neurologix Forges Ahead on Gene Therapy Treatment for Parkinson’s	Arlene Weintraub	06/23/11	New York
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News	Erin Kutz	05/27/11	Boston
Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy	Luke Timmerman	05/23/11	Boston
Sangamo Shows Early Promise Against HIV, Hemophilia at Gene Therapy Revival Meeting	Luke Timmerman	05/23/11	San Francisco
The Resurgence of Gene and Cell Therapy	Barrie Carter	05/16/11	Seattle
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate	Ryan McBride	04/20/11	Boston
Bluebird Bio Inks AFM Development Deal	Gregory T. Huang	03/16/11	Boston
Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News	Luke Timmerman	03/10/11	Seattle
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London	Luke Timmerman	03/09/11	Seattle
Stewart Parker Joins IDRI as New CEO, Bringing Biotech Sensibility to Global Health Effort	Luke Timmerman	02/15/11	Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News	Luke Timmerman	11/18/10	Seattle
Targeted Genetics Seeks Merger	Luke Timmerman	11/12/10	Seattle
Ceregene Adds $11.5M	Luke Timmerman	11/11/10	San Diego
Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker	Luke Timmerman	10/18/10	San Francisco
Xconomy Boston’s Top 20 Stories of the Third Quarter: From A123 Expansion to Zynga Acquisition	Gregory T. Huang	10/01/10	Boston
Bluebird Bio, Third Rock & Genzyme’s Gene Therapy Bet, Shows Promise for Blood Disorder	Luke Timmerman	09/15/10	Boston
Seattle Children’s Moves in at Prominent Biotech Address as Targeted Genetics Moves Out	Luke Timmerman	08/18/10	Seattle
Third Rock Ventures, Firm With Hunger for Audacious Biotech Ideas, Sets up SF Shop	Luke Timmerman	08/12/10	San Francisco
Gail Maderis, the Boston Biotech Exec Who Came Home to SF, Seeks to Give Back at BayBio	Luke Timmerman	07/08/10	San Francisco
Ceregene Gets $2.5M From Fox Foundation	Bruce V. Bigelow	06/23/10	San Diego
Feds’ Sequenom Probe Breaks Into the Open, Life Technologies Moves Into Synthetic Biology, DexCom Agrees to Re-Label Its Medical Devices, & More San Diego Life Sciences News	Bruce V. Bigelow	06/03/10	San Diego
Ending the Suspense, Celladon’s Gene Therapy Helps Heart Failure Patients in Small Study	Luke Timmerman	06/01/10	San Diego
Celladon Enjoys Early Success With Gene Therapy Trial, FDA Gives Digirad Green Light for a Nuclear Camera, Aragon Pharmaceuticals Gets $22M & More San Diego Biotech News	Bruce V. Bigelow	04/29/10	San Diego
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details	Luke Timmerman	04/28/10	San Diego
Sensata and Aveo Go Public; Genetix, Rhythm, and CorrelSense Get Funding; Pegasystems to Acquire Chordiant; & More Boston-Area Deals News	Erin Kutz	03/17/10	Boston
Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy	Ryan McBride	03/12/10	Boston
West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News	Denise Gellene	03/11/10	San Diego
Page 1 of 3	next page »